Cargando…
Intravesical therapy for urothelial carcinoma of the bladder
Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical ag...
Autor principal: | Manoharan, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142838/ https://www.ncbi.nlm.nih.gov/pubmed/21814318 http://dx.doi.org/10.4103/0970-1591.82846 |
Ejemplares similares
-
The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019) -
Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy
por: Li, Gang, et al.
Publicado: (2017) -
Intravesical Therapy for Upper Urinary Tract Urothelial Carcinoma: A Comprehensive Review
por: Wang, Zheng, et al.
Publicado: (2023) -
Bacillus Calmette–Guerin intravesical instillation therapy-induced urothelial necrosis of the bladder and upper urinary tract
por: Kondo, Tsubasa, et al.
Publicado: (2022) -
Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)